Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Zhaoping Li, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT01076829
First received: February 25, 2010
Last updated: June 9, 2014
Last verified: December 2013

February 25, 2010
June 9, 2014
July 2009
June 2014   (final data collection date for primary outcome measure)
The protocol is designed to study the effect of spice on MDA production in hamburg meat [ Time Frame: 2 days ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01076829 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes
Inhibition of Absorption of Cytoxic Lipid Peroxidation Products and Abnormalities of Postprandial Endothelial Function by Spice Polyphenols Fed Together With High Fat Meat Patty in Men With Type 2 Diabetes Mellitus or Impaired Glucose Tolerance

Polyphenols belong to the largest group of secondary metabolites produced by plants, mainly, in response to biotic or abiotic stresses such as infections, wounding, UV irradiation, exposure to ozone, pollutants, and other hostile environmental conditions. It is thought that the molecular basis for the protective action of polyphenols in plants is their antioxidant and free radical scavenging properties. These numerous phenolic compounds are major biologically active components of spices, aromas, essential oils, and traditional medicines. In order to investigate the impact of spice polyphenols on postprandial flow-mediated dilation, nitric oxide, glucose, insulin, triglycerieds, oxidized LDL, and cytoxic lipid peroxidation products (MDA) levels in men with type 2 diabetes, the investigators propose to achieve the following specific aims using a randomized crossover study design:

  1. To determine the effect of a ground beef patty meal with and without polyphenol-rich spices on postprandial levels of plasma oxidized LDL, triglycerides, insulin, glucose, and malondialdehyde (MDA).
  2. To determine the effect of a ground beef patty meal with and without polyphenol-rich spices on postprandial levels of nitric oxide and flow-mediated dilation.
  3. To determine the effect of a ground beef patty meal with and without a spice blend on MDA accumulation in urine.

This study will determine whether spice polyphenols exert a beneficial effect by inhibition of the absorption of lipotoxin MDA in males with type 2 diabetes mellitus.Men with diabetes mellitus type 2 have been selected for this study to enable assessment of markers of vascular health including nitric oxide in plasma and flow-mediated dilation. These findings may help to explain the potentially harmful effects of oxidizable fats found in foods and the important benefit of dietary polyphenols in ameliorating this potentially harmful effect.

10 male subjects with type 2 diabetes mellitus who will be recruited based on inclusion and exclusion criteria. The study will be carried out in accordance with the guidelines of the Human Subjects Protection Committee of the University of California, Los Angeles. All subjects will give written informed consent before the study begins. After the screening visit, each subject will come to the Center for Human Nutrition on two 1-day test phases separated by at least one week. At each of phases, subjects will consume, in a random order, two different test meals consisting of either: a) a ground dark meat beef patty seasoned with salt only, or b) a ground dark meat beef patty seasoned with a spice mixture and salt. The subjects will be asked to avoid eating high fat meat meals and all spice products for 3 days before the day of each of the two experimental phases

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science
Type II Diabetes Mellitus
Other: Spice polyphenols
spice
  • Active Comparator: Spice patty
    hamburger meat cooked with spice mixture
    Intervention: Other: Spice polyphenols
  • Placebo Comparator: salt patty
    Subjects consume salt containing hamburger meat
    Intervention: Other: Spice polyphenols
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
10
June 2014
June 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Have a diagnosis of Type II Diabetes Mellitus and currently being treated with oral medication but no insulin or glucose intolerant on no medications with a fasting blood sugar of > 110 mg/dl but less than 126 mg/dl fasting.
  • Have an HbA1C lvel <9 % at Screening
  • Male 35-70 years old
  • Non-smokers, or smoke < 1 cigarette per day
  • Must weigh a minimum of 110 pounds
  • Willing to maintain normal activity and eating patterns for the duration of the study
  • Willing to avoid meat, fish or poultry for three days on two occasions prior to the test procedure
  • Consuming less than two alcoholic drinks per day
  • Not taking dietary supplements
  • No known allergy to beef, cloves, cinnamon, oregano, turmeric, cumin, rosemary, sage, red pepper, ginger, black pepper, paprika or garlic

Exclusion Criteria:

  • Currently using insulin
  • Abnormal liver function
  • Currently taking steroidal drugs
  • Known HIV positive or AIDS
  • Chronic infectious disease
  • Cancer treated within the past two years
  • Participation in a therapeutic research study within 30 days of baseline
  • Allergy to beef, cloves, cinnamon, oregano, rosemary, ginger, black pepper, paprika or tumeric
  • History of hear failure with EF < 30, chronic renal failure with GFR < 30 ml/min
  • Currently taking vasoactive medications such as but not limited to calcium channel blockers, nitrates, beta blockers, phosphodiesterase inhibitors
  • History of Raynauds
  • History of smoking within 5 years
Male
35 Years to 70 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01076829
08-11-023
No
Zhaoping Li, University of California, Los Angeles
University of California, Los Angeles
Not Provided
Principal Investigator: Zhaoping Li, MD University of California, Los Angeles
University of California, Los Angeles
December 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP